All In Biotech

Free tool

FAERS Monitor: Pepcid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019462 or its brand name (Pepcid, Famotidine). Reports on generic versions are filed under their own applications.

Reports

108,916

Serious

72,067

66% of reports

Hospitalization

36,851

Death reported

10,362

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea7,536
  • fatigue7,230
  • diarrhoea6,752
  • off label use5,562
  • dyspnoea5,538
  • chronic kidney disease5,512
  • drug ineffective5,229
  • headache5,172
  • pain4,635
  • vomiting4,570
  • dizziness4,268
  • acute kidney injury4,134
  • death3,825
  • pneumonia3,658
  • renal failure3,580

Reports by year received

View as table
YearReports
20041,480
20051,344
20061,306
20071,066
20081,323
20091,278
20101,762
20112,421
20123,117
20131,821
20142,162
20153,445
20164,042
20174,323
20185,599
20196,908
20208,543
20218,397
20228,912
20238,921
202410,265
202511,235
20269,239

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,945,243 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal5,51215.014.667,163
acute kidney injurySignal4,1345.35.214,263
renal failureSignal3,5805.35.212,302
pneumoniaSignal3,6582.22.12,390
diarrhoeaSignal6,7522.02.03,605
dyspnoea5,5381.91.82,393
vomiting4,5701.91.81,925
nausea7,5361.81.83,011
fatigue7,2301.81.82,648
dizziness4,2681.71.61,131
headache5,1721.61.61,182
pain4,6351.51.4688
off label use5,5621.21.2244
death3,8250.90.895
drug ineffective5,2290.80.7400

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.